Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.24.1.1.u2
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Licensing revenues: $ 675
Operating expenses:    
Research and development 6,813 3,030
General and administrative 2,391 1,847
Total operating expenses 9,204 4,877
Loss from operations (9,204) (4,202)
Other income (expenses):    
Interest income 69 14
Interest expense (20) (12)
Change in fair value of warrant liability (11,808) (10,375)
Total other income (expenses) (11,759) (10,373)
Net loss (20,963) (14,575)
Dividend to preferred stockholders (208) (192)
Net loss attributable to common stockholders $ (21,171) $ (14,767)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.61) $ (0.97)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares) 34,912,692 15,232,406
Series A-1 preferred stock    
Other income (expenses):    
Dividend to preferred stockholders   $ (192)